Riskpilot← Back to searchSign inGet full accessStemma AB
ABActiveOrg 5567102305Pråmviken 188Other human health activities n.e.c. · NACE 8699Est. 20061 employees
Revenue 2025
SEK 244K
-9% vs 2024
EBITDA margin
-8.2%
-633% vs 2024
Equity ratio
63.2%
Financial strength
Net profit 2025
SEK 79K
-11% vs 2024
| Revenue | SEK 244K | -9% |
| EBITDA | SEK -20K | -633% |
| Net profit | SEK 79K | -11% |
| Total assets | SEK 292K | -28% |
| Equity | SEK 184K | -10% |
| Employees | 1 | — |
Legal name
Stemma AB
Org number
5567102305
Legal form
Aktiebolag
NACE code
8699 · Other human health activities n.e.c.
Founded
4 september 2006
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall bedriva konsultverksamhet, utbildning och försäljning inom hälso- och sjukvård, medicin, läkemedel och kemi samt äga och förvalta fast egendom ävensom idka därmed förenlig verksamhet.
Address
Pråmviken 188
Phone
+4618551267
Email
mats@stemma.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 158 | 202 | 233 | 269 | 244 |
| Staff expenses | — | −314 | −232 | −222 | −265 |
| EBITDA | −109 | −160 | −16 | 4 | −20 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | −109 | −160 | −16 | 4 | −20 |
| Net financials | — | — | 2 | 79 | 12 |
| Profit before tax | −7 | −13 | −5 | 114 | 103 |
| Tax | −0 | — | — | −25 | −24 |
| Net profit | −7 | −13 | −5 | 89 | 79 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 097 | 939 | 920 | 403 | 292 |
| Equity | 735 | 721 | 716 | 205 | 184 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 26 | 28 | 22 | 48 | 69 |
| Total debt | 26 | 28 | 22 | 48 | 69 |
EBITDA margin
-8.2%
This company
15.8%
Market median
-152% vs market
20212025
Equity ratio
63.2%
This company
38.2%
Market median
+65% vs market
20212025
Return on equity
43.0%
This company
18.4%
Market median
+134% vs market
20212025
Net profit margin
32.5%
This company
8.1%
Market median
+301% vs market
20212025
Asset turnover
0.84×
This company
1.12×
Market median
+25% vs market
20212025
Debt / equity
0.58×
This company
0.62×
Market median
+6% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AE Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Stemma AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Aina Eva-Marie Stridsberg | Chief Executive Officer | 0 companies |
| Mats Ingvar Stridsberg | Board of Directors | 0 companies |